Rohan Palekar, Chief Executive Officer
Rohan Palekar currently serves as Chief Executive Officer and a member of the Board of Directors of 89Bio. Prior to 89Bio, Mr. Palekar held various positions at Avanir Pharmaceuticals, most recently as President and Chief Executive Officer, where he led the company following its acquisition by Otsuka Pharmaceutical. Prior to the acquisition, Mr. Palekar served as Avanir’s Executive Vice President and Chief Operating Officer, and as Senior Vice President and Chief Commercial Officer. Prior to joining Avanir, he served as Chief Commercial Officer for Medivation. Mr. Palekar also spent over 16 years at Johnson & Johnson in various senior commercial and strategic management roles. He currently serves as Chairman of the Board of Trustees as a trustee for Aim High for High School, and previously served as a member of the Board of Directors of Neoleukin Therapeutics. Mr. Palekar earned his M.B.A. from the Tuck School of Business at Dartmouth College, his B.Com. in Accounting from the University of Mumbai, and his L.L.B. from the University of Mumbai. He is a certified Chartered Accountant and a Cost and Management Accountant.